Treatment of acute myeloid leukemia with
β
Dr. David Machover; Henry Rappaport; LΓ©on Schwarzenberg; Jean-Louis Misset; Emma
π
Article
π
1984
π
John Wiley and Sons
π
English
β 660 KB
The authors developed a therapeutic regimen in which 33 patients aged I I to 61 years (mean 2 SE, 35.9 t 2.3 years) with acute myeloid leukemia (AML) were given intensive induction chemotherapy with Adriamycin (doxorubicin) (ADM), vincristine (VCR) and cytosine arabinoside (ARA-C). Twenty-nine of th